Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGLIF.L Regulatory News (GLIF)

  • There is currently no data for GLIF

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

NAV Update for the quarter ended 31 March 2011

23 May 2011 10:00

RNS Number : 0765H
Greenwich Loan Income Fund Ltd
23 May 2011
 



23 May 2011

 

Greenwich Loan Income Fund Limited

 

NAV Update for the quarter ended 31 March 2011

 

Greenwich Loan Income Fund Limited ("GLIF" or "the Company") announces that as at 31 March 2011, its unaudited net asset value (NAV) per share was 70.3p. This compares to the final reported NAV of 79.2p per share as at 31 December 2010.

 

The weighted average market bid for the Company's investment portfolio at the quarter end was 95.5% of par, and for the liabilities, 85.2%. This compares to last quarter's figures of 93.4% of par and 82.2% respectively. The change in NAV resulted from the issuance of shares below NAV per share in connection with the acquisition of AMIC PLC, as well as the somewhat larger upward movement in the fair value of liabilities compared to portfolio assets. There was also a slight offset to these factors resulting from the modest strengthening of the GBP against the US dollar from year-end to 31 March.

 

As previously described to shareholders, under International Financial Reporting Standards (IFRS), the consolidated results of operations for the Company include the impact of carrying its investments and its liabilities at fair value. Shareholders should be aware that the Company's realisation of the full NAV is unlikely. The NAV, as calculated in accordance with IFRS, reflects the theoretical fair value of the liabilities of the CLO but, because the market is rather illiquid, it may be difficult for the Company to acquire any or a significant portion of those liabilities.

 

It should also be noted, as announced on 27 April 2011, that the Company is reviewing its exposure to T2 CLO I Ltd ("the CLO"), and were the CLO to no longer be consolidated in the future, the Company would carry its interest in CLO paper at fair value as determined by the Board of Directors. The Company expects that the resultant carrying value would be less than the proportionate share of NAV represented by the retained CLO interest as currently calculated under IFRS because it would no longer reflect the marking to market of liabilities below par. As a result, the net asset value determined post-deconsolidation of the CLO should be more comparable to other listed loan-focused investment companies.

 

The other two values customarily calculated to provide further clarity as to the dynamics within the value of the business are as follows:

 

- the value based upon assets at market value and liabilities at par was 50.2p per share as at 31 March 2011, compared to 45.4p per share as at 31 December 2010.

 

- the value based upon CLO assets as calculated for interest diversion purposes, remaining assets at market, and liabilities at par was 54.0p per share as at 31 March 2011, compared to 52.8p as at 31 December 2010.

 

The portfolio statistics on the Company's website (www.glifund.com) have been updated to include the most recent quarter. The CLO portfolio continues to increase in credit quality (as measured by the weighted average rating test) over the past year, whilst the weighted average spread (not taking into account LIBOR floors) has also increased. One major trend within the portfolio has been the increasing level of prepayments, averaging approximately 10% per quarter for the past year. During this period, the Company's investment manager has been able to deploy the capital successfully and in a manner consistent with the Company's investment objectives.

 

 

Contacts:

 

Geoffrey Miller

Greenwich Loan Income Fund Limited

+353 1 4433 466

 

Patrick Conroy

Greenwich Loan Income Fund Limited

+1 203 983 5282

 

Philip Secrett

Nominated Adviser

Grant Thornton Corporate Finance

+44 207 383 5100

 

James Maxwell

Singer Capital Markets Limited

+44 (0) 20 3205 7622

 

Ed Gascoigne Pees

Financial Dynamics

+44 (0) 207 269 7132

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NAVGIGDUCSDBGBX
Date   Source Headline
10th Jul 20187:00 amRNSTransaction in Own Shares & Total Voting Rights
3rd Jul 20187:00 amRNSSale of loan assets
20th Jun 20183:14 pmRNSHolding(s) in Company
11th May 20181:51 pmRNSResult of AGM
19th Apr 20189:11 amRNSHolding(s) in Company
13th Apr 201812:30 pmRNSAnnual Report and Accounts & Notice of AGM
10th Apr 20183:44 pmRNSUpdate on FinTech platform
28th Mar 20185:31 pmRNSDirector/PDMR Shareholding
26th Mar 20187:00 amRNSFinal Results for the Year Ended 31 December 2017
28th Feb 20189:14 amRNSFirst draw-down of the HIT funding-facility
29th Jan 201811:05 amRNSSecond Price Monitoring Extn
29th Jan 201811:00 amRNSPrice Monitoring Extension
29th Jan 20187:02 amRNSRepayment of Sancus Loan Note 1
29th Jan 20187:00 amRNSNew Funding Facility
12th Jan 20187:00 amRNSDirector/PDMR Shareholding
10th Jan 201812:03 pmRNSHolding(s) in Company
21st Dec 201712:43 pmRNSDirector/PDMR Shareholding
24th Nov 20177:00 amRNSFurther investment in Sancus Isle of Man
23rd Nov 20174:30 pmRNSChange of Registered Office
26th Sep 20174:30 pmRNSGrant of Options
25th Sep 20173:38 pmRNSLaunch of third securitised loan note SPV
25th Sep 20177:00 amRNSInterim Results
10th Aug 20179:05 amRNSTR-1: NOTIFICATION OF MAJOR HOLDINGS
14th Jul 20171:00 pmRNSFundingKnight granted full FCA authorisation
10th Jul 20175:11 pmRNSDirector/PDMR Shareholding
3rd Jul 20178:53 amRNSIncrease in stake in Sancus Finance Limited
25th May 201710:15 amRNSDirector/PDMR Shareholding
12th May 20172:31 pmRNSChange in Senior Management Team
10th May 20174:49 pmRNSResult of Annual General Meeting
2nd May 20177:00 amRNSInvestment in second securitised loan note SPV
27th Apr 20174:44 pmRNSDirector/PDMR Shareholding
20th Apr 20177:00 amRNSSCRIP DIVIDEND SHARES - ADDITIONAL LISTING
13th Apr 20179:02 amRNSAnnual Report & Accounts & Notice of AGM
27th Mar 201711:59 amRNSAnnual Report & Accounts, year ended 31.12.16
27th Mar 20177:02 amRNSConsolidatedFinancial Statements year end 31.12.16
27th Mar 20177:02 amRNSFurther investment in Sancus Isle of Man
13th Mar 20177:00 amRNSTrading Update
10th Mar 20172:30 pmRNSHolding(s) in Company
8th Mar 20179:05 amRNSSecond Price Monitoring Extn
8th Mar 20179:00 amRNSPrice Monitoring Extension
8th Mar 20177:00 amRNSProposals Re. The SME Loan Fund plc - Update
24th Feb 20174:35 pmRNSPrice Monitoring Extension
22nd Feb 20178:59 amRNS2016 Fourth Interim Dividend
21st Feb 20177:03 amRNSProposals Re. The SME Loan Fund plc
6th Feb 201710:15 amRNSFurther investment in Sancus Isle of Man
19th Jan 20173:03 pmRNSDirector / PDMR Shareholding - Replacement
19th Jan 201712:44 pmRNSDirector/PDMR Shareholding
11th Jan 20175:01 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
4th Jan 20171:19 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
4th Jan 20171:18 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.